Home - Australian Pharmacist

Summer of fun?

AP Staff - November 28, 2000

Advertorial

As medicinal cannabis prescriptions climb, does the evidence hold up?

Chloe Hava - September 1, 2000

Industry

Medicinal cannabis prescribing in Australia has risen sharply in recent years, with the Therapeutic Goods Administration (TGA) recording thousands of approvals each month under...

Motion sickness

AP Staff - August 5, 2000

CPD

References Murdin L, Golding J, Bronstein A. Managing motion sickness. BMJ 2011;343(7835):1213-7 Golding JF. Motion sickness susceptibility. Auton Neurosci. 2006;129(1-2):67-76. Takov V, Tadi P....

Time to vent: changes to asthma management in adults and adolescents

AP Staff - August 20, 2000

CPD

FIP: ‘Embrace new opportunities’

Peter Guthrey FPS - September 1, 2000

Industry

The International Pharmaceutical Federation (FIP) Congress opened overnight in Copenhagen, honouring some of the world’s leading pharmacists.

Sun safety: don’t feel the burn

Victor Senescall MPS - August 20, 2000

CPD

1...305306307 Page 306 of 307

How do paracetamol and ibuprofen increase antimicrobial resistance?

Are there certain populations who could be more at risk?

What advice should pharmacists provide to patients?

Challenges of repackaging medicines

Patient storage practices: a critical factor

Best practices for medicine storage at home

The pharmacist’s role in providing medicines information

References

What’s driving these trends?

What role is prescribing playing?

What are the bottlenecks to ORT access?

What else needs to change?

What does the evidence say?

Will Ozempic be PBS listed for CKD?

With Ozempic no longer in shortage, will access open up?

How do paracetamol and ibuprofen increase antimicrobial resistance?

Are there certain populations who could be more at risk?

What advice should pharmacists provide to patients?

Challenges of repackaging medicines

Patient storage practices: a critical factor

Best practices for medicine storage at home

The pharmacist’s role in providing medicines information

References

What’s driving these trends?

What role is prescribing playing?

What are the bottlenecks to ORT access?

What else needs to change?

What does the evidence say?

Will Ozempic be PBS listed for CKD?

With Ozempic no longer in shortage, will access open up?

How do paracetamol and ibuprofen increase antimicrobial resistance?

Are there certain populations who could be more at risk?

What advice should pharmacists provide to patients?

Challenges of repackaging medicines

Patient storage practices: a critical factor

Best practices for medicine storage at home

The pharmacist’s role in providing medicines information

References

What’s driving these trends?

What role is prescribing playing?

What are the bottlenecks to ORT access?

What else needs to change?

What does the evidence say?

Will Ozempic be PBS listed for CKD?

With Ozempic no longer in shortage, will access open up?

How do paracetamol and ibuprofen increase antimicrobial resistance?

Are there certain populations who could be more at risk?

What advice should pharmacists provide to patients?

Challenges of repackaging medicines

Patient storage practices: a critical factor

Best practices for medicine storage at home

The pharmacist’s role in providing medicines information

References

What’s driving these trends?

What role is prescribing playing?

What are the bottlenecks to ORT access?

What else needs to change?

What does the evidence say?

Will Ozempic be PBS listed for CKD?

With Ozempic no longer in shortage, will access open up?

Subscribe to our newsletter

Subscribe to our newsletter

CONTACT

FOLLOW US